Antibiotics (Basel)
October 2022
Background: Ceftazidime/avibactam (CZA) is a new option for the treatment of KPC-producing Klebsiella pneumoniae. The aim of this study was to determine resistance patterns and carbapenemase genes among K. pneumoniae (CP-Kp) bacteremic isolates before and after CZA introduction.
View Article and Find Full Text PDFBackground: After mild COVID-19, some outpatients experience persistent symptoms. However, data are scarce and prospective studies are urgently needed.
Objectives: To characterize the post-COVID-19 syndrome after mild COVID-19 and identify predictors.
Biomed Res Int
December 2020
Background: Coronavirus disease 2019 (COVID-19) can result in profound changes in blood coagulation. The aim of the study was to determine the incidence and predictors of venous thromboembolic events (VTE) among patients with COVID-19 requiring hospital admission. .
View Article and Find Full Text PDF